The INFLUENCE 3.0 model: updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy
Authors:
Preprint
- 6 December 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Background Individual risk prediction of 5-year locoregional recurrence (LRR) and contralateral breast cancer (CBC) supports decisions regarding personalised surveillance. The previously developed INFLUENCE tool was rebuild, including a recent population and patients who received neoadjuvant systemic therapy (NST). Methods Women, surgically treated for nonmetastatic breast cancer, diagnosed between 2012-2016, were selected from the Netherlands Cancer Registry. Cox regression with restricted cubic splines was compared to Random Survival Forest (RSF) to predict five-year LRR and CBC risks. Separate models were developed for NST patients. Discrimination and calibration were assessed by 100x bootstrap resampling. Results In the non-NST and NST group, 49,631 and 10,154 patients were included, respectively. Age, mode of detection, histology, sublocalisation, grade, pT, pN, hormonal receptor status±endocrine treatment, HER2 status±targeted treatment, surgery±immediate reconstruction±radiation therapy, and chemotherapy were significant predictors for LRR and/or CBC in non-NST patients. For NST patients this was similar, but excluding (y)pT and (y)pN status, and including presence of ductal carcinoma in situ, axillary lymph node dissection and pathologic complete response. For non-NST patients, the Cox and RSF models were integrated in the online tool with 5-year AUCs of 0.77 (95%CI:0.77-0.77) and 0.68 (95%CI:0.67-0.68)] for LRR and CBC prediction, respectively. For NST patients, the RSF model performed best (AUCs 0.77 (95%CI:0.76-0.78) and 0.73 (95%CI:0.69-0.76) for LRR and CBC, respectively). Regarding calibration, observed-predicted differences were all <1%. Conclusion This INFLUENCE 3.0 models showed moderate performance in LRR and CBC prediction. The models have been made available as online tool to enable clinical decision support regarding personalised follow-up.Keywords
All Related Versions
This publication has 37 references indexed in Scilit:
- Utilization of neoadjuvant chemotherapy in high‐risk, node‐negative early breast cancerCancer Medicine, 2022
- Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017International Journal of Cancer, 2020
- Graphical calibration curves and the integrated calibration index (ICI) for survival modelsStatistics in Medicine, 2020
- Ten‐year recurrence rates for breast cancer subtypes in the Netherlands: A large population‐based studyInternational Journal of Cancer, 2018
- Socioeconomic status and breast cancer treatmentBreast Cancer Research and Treatment, 2017
- Corrected ROC analysis for misclassified binary outcomesStatistics in Medicine, 2017
- Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patientsBreast Cancer Research and Treatment, 2015
- General Aspects of Fitting Regression Models2015
- Overfitting and optimism in prediction models2008
- Tutorial in biostatistics: competing risks and multi‐state modelsStatistics in Medicine, 2006